UnknownNot Applicable

Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients

France1,000 participantsStarted 2017-03-15

Plain-language summary

The analysis of a cohort of consecutive non-selected patients from the Strasbourg University Hospital, and therefore representative of the real life, will allow better identifying the risk factors for these infections (by comparison with a cohort of patient with similar conditions of immunosuppression and no infection) and improving the diagnosis and therapeutic management. The primary objective is to identify prognosis factors affecting survival in patients with opportunistic infections

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Non selected consecutive immunocompromised or frail patients with an opportunistic infection * Hospitalized in any of the department of the University Hospital of Strasbourg * For epidemiological study, patients with similar immunodepression of frail condition and no opportunistic infection Exclusion criteria: \- Opposition of the patient to use his personal data

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Short- and long-term survival, overall and in specific subgroups of patients

Timeframe: Long-term time point : 1st may 2019

Short- and long-term survival, overall and in specific subgroups of patients

Timeframe: Short term : 1 month

Short- and long-term survival, overall and in specific subgroups of patients

Timeframe: Short term : 3 months

Short- and long-term survival, overall and in specific subgroups of patients

Timeframe: Short term : 6 months

Trial details

NCT IDNCT03920735

SponsorUniversity Hospital, Strasbourg, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-07-15

Contact for this trial

Raoul HERBRECHT, MD

03 88 12 83 79 raoul.herbrecht@chru-strasbourg.fr

View on ClinicalTrials.gov More Hematologic Disease trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Short- and long-term survival, overall and in specific subgroups of patients

Timeframe: Long-term time point : 1st may 2019

Short- and long-term survival, overall and in specific subgroups of patients

Timeframe: Short term : 1 month

Short- and long-term survival, overall and in specific subgroups of patients

Timeframe: Short term : 3 months

Short- and long-term survival, overall and in specific subgroups of patients

Timeframe: Short term : 6 months